PRENOXAD 0.91 mg/ml, solution for injection in a pre-filled syringe syringe, 2 ml
Active ingredients: Naloxone hydrochloride, Naloxone hydrochloride dihydrate
Commercialized according to BDPM
Solution for injectionsyringe, 2 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PRENOXAD 0,91 mg/ml, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 1 seringue préremplie en verre de 2 ml avec 2 aiguilles
- Marketing authorisation holder
- ETHYPHARM
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 Jun 2019
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62968616CIP73015457CIP133400930154571Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE NALOXONE ANHYDREsolution | 0,91 mg · 1 mL de solution | FT |
| CHLORHYDRATE DE NALOXONE DIHYDRATÉsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.